3,4-Methylenedioxy-N-methoxyamphetamine

3,4-Methylenedioxy-N-methoxyamphetamine (MDMEO, MDMEOA, or MDMeOA) is a drug and a substituted amphetamine.^[1] It is also the N-methoxy analogue of MDA. MDMEO was first synthesized by Alexander Shulgin.^[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dose is listed as 180 mg.^[1] MDMEO may be found as white crystals.^[1] It produces few to no effects.^[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEO.^[1]

MDMEO

Clinical data
Other names	MDMEO; MDMEOA; MDMeOA
Routes of administration	Oral[1]
ATC code	None
Pharmacokinetic data
Duration of action	Unknown[1]
Identifiers
IUPAC name 1-(2H-1,3-benzodioxol-5-yl)-N-methoxypropan-2-amine
CAS Number	74698-48-9 Y
PubChem CID	44719583
ChemSpider	21106333 Y
UNII	2N67Z48J84
CompTox Dashboard (EPA)	DTXSID50660370
Chemical and physical data
Formula	C11H15NO3
Molar mass	209.245 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(NOC)Cc1ccc2OCOc2c1
InChI InChI=1S/C11H15NO3/c1-8(12-13-2)5-9-3-4-10-11(6-9)15-7-14-10/h3-4,6,8,12H,5,7H2,1-2H3 Y Key:MTIKJUJMCMDSGM-UHFFFAOYSA-N Y
(verify)

Society and culture

Legal status

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[2]

See also

• Substituted methylenedioxyphenethylamines